A Vaccine against Nicotine for Smoking Cessation: A Randomized Controlled Trial. 25. Juni 2008, doi:10.1371/journal.pone.0002547.
Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. 14. Juni 2011, doi:10.1111/j.1365-2222.2011.03783.x.
Quirin Schiermeier: Nobel laureate slams misconduct smear. In: Nature. Band421, Nr.6925, 1. Februar 2003, ISSN1476-4687, S.773–773, doi:10.1038/421773b (nature.com [abgerufen am 13. September 2022]).
nature.com
Quirin Schiermeier: Nobel laureate slams misconduct smear. In: Nature. Band421, Nr.6925, 1. Februar 2003, ISSN1476-4687, S.773–773, doi:10.1038/421773b (nature.com [abgerufen am 13. September 2022]).
nih.gov
ncbi.nlm.nih.gov
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. 4. Februar 2013, PMID 23384679.
Treating insect-bite hypersensitivity in horses with active vaccination against IL-5. 4. April 2018, PMID 29627082.
Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. 4. April 2018, PMID 29627081.
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. 2. Mai 2019, PMID 31056187.